Colorado Blood Cancer Institute at HealthOnes Sarah Cannon Cancer Institute at Presbyterian/St. Luke's Medical Center
Locations
Transplant Summary
Overview
The Colorado Blood Cancer Institute at Presbyterian St. Luke's Medical Center is the largest most comprehensive transplant program in the Rocky Mountain Region. We offer allogeneic, autologous, cord blood and haploidentical transplantation for all hematologic and malignant disease indications. In addition, we also offer CAR-T cell therapy and a wide variety of innovative treatment protocols and research studies.This center has been performing allogeneic transplants since 1991 and has been an NMDP transplant center since May 1997.
Attending physicians
Adult - Scott I. Bearman, Alireza Eghtedar, Tara K. Gregory, Michael Maris, Jeffrey V. Matous, Luke Mountjoy, Richard A. Nash, Marcello Rotta, Henning Schade, Michael Tees
Pediatric - James Bradley Ball, Jennifer Clark, John vanDoorninck, Julie ZimbelmanTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
Our CBCI Long Term Follow Up/ Survivorship Program has been established for over a decade. Patients are seen by an advanced practice provider or physician at 1 year post stem cell transplant and annually thereafter. The assessment and education is focused on long-term effects, vaccinations, secondary cancer prevention, reproductive health, medications and mental health. We provide multidisciplinary post-transplant care to all of our patients. Allogeneic patients are followed closely by a specially trained RN serving as the primary contact providing a continuum of care after discharge from the hospital.
Our Cancer Care Nutrition team is available for pre-treatment consultation to maximize your nutritional status prior to therapy. Our team also provides inpatient and outpatient support and consultation during treatment and post-treatment to maximize your recovery. Each member of our nutrition team has a special interest in oncology and a nutrition sub-specialty that provides an expert nutrition knowledge base related to cancer, blood disorders, autoimmune disorders and stem cell transplantation.
Our psychosocial team consists of social workers that have been trained to meet the needs of our patient population. They establish a relationship with patients prior to transplant and support them throughout the transplant process as their needs evolve. This includes addressing financial concerns and steering recipients to potential grant options They also support families and caregivers as needed.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 332 patients.The actual 1-year survival of these patients is 73.1%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 71% and 79.8%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
619
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow9PBSC60Cord blood0Total69Unrelated donorMarrow2PBSC183Cord blood2Total187Total allogeneicMarrow11PBSC243Cord blood2Total256AutologousMarrowBoth marrow & PBSC 363PBSC—Cord blood—Total363Total combinedMarrowBoth marrow & PBSC 617PBSC—Cord blood2Total619Total pediatric transplants
3
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow0PBSC0Cord blood0Total0Unrelated donorMarrow0PBSC0Cord blood0Total0Total allogeneicMarrow0PBSC0Cord blood0Total0AutologousMarrowBoth marrow & PBSC 3PBSC—Cord blood—Total3Total combinedMarrowBoth marrow & PBSC 3PBSC—Cord blood0Total3All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-442045-643865+11Total69Unrelated 0-18019-443245-646765+88Total187Autologous 0-18319-445345-6415765+153Total366Total 0-18319-4410545-6426265+252Total622Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Colorado Blood Cancer Institute
1721 E. 19th Ave. Suites 200-300 Denver, CO 80218 Phone:720-754-4800 For more information about this program: https://bloodcancerinstitute.com (Opens in a new tab)Overview
Our transplant team includes program psychologists, social workers, dietitians, advanced practice providers, medical assistants, financial and transplant nurse coordinators, and blood and marrow certified registered nurses. Our Long Term Follow Up Program manages the possible complications of our allogeneic patients' Graft Versus Host Disease (GVHD). We not only follow the patient but are also a resource for our referring physicians whose patients have returned to their care. For autologous transplant patients, someone from the LTFU department will be present during your exit interview from our clinic as you are redirected to the care of your referring oncologist. You will have a complete examination, lab work, discussion about discharge guidelines to follow at home, and you will receive an outline of post-transplant staging studies. All of this information will be sent to your referring oncologist as well. Following the exit interview, we recommend follow-up visits with our clinic at specific intervals that will be determined by your transplant physician. For allogeneic transplant patients, the LTFU department will see you around 3-6 months after your transplant. You will undergo a complete physical evaluation, lab work, surveillance for post-transplant complications, a nutritional evaluation, and a consult with our psychologist or social worker if needed. Prior to some of these visits, you may be given a screening questionnaire to focus on any physical, emotional, or social concerns. When you are one year out of transplant, both autologous and allogeneic transplant patients will receive information in the mail regarding recommendations for a first annual post-transplant workup. Any questions about this workup should be directed to the LTFU department.
Staff
Program Director:Richard A Nash, MDProgram Coordinator:Julie Sinnema, RNPatient Eligibility
Adults- Adults: 100days after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital